Patents by Inventor Alan Halpern

Alan Halpern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190388560
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for treatment of disease and/or injury.
    Type: Application
    Filed: September 5, 2019
    Publication date: December 26, 2019
    Inventors: Jeffrey L. GOLDBERG, Alan HALPERN
  • Patent number: 10406242
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for treatment of disease and/or injury.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: September 10, 2019
    Assignee: Emmetrope, Inc.
    Inventors: Jeffrey L. Goldberg, Alan Halpern
  • Publication number: 20180154021
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for treatment of disease and/or injury.
    Type: Application
    Filed: December 4, 2017
    Publication date: June 7, 2018
    Inventors: Jeffrey L. Goldberg, Alan Halpern
  • Patent number: 9833517
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. For treatment of disease and/or injury.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: December 5, 2017
    Assignee: EMMETROPE, INC.
    Inventors: Jeffrey L. Goldberg, Alan Halpern
  • Publication number: 20160089452
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. For treatment of disease and/or injury.
    Type: Application
    Filed: July 13, 2015
    Publication date: March 31, 2016
    Applicant: EMMETROPE, INC.
    Inventors: Jeffrey L. GOLDBERG, Alan Halpern
  • Patent number: 9078932
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for treatment of disease and or injury.
    Type: Grant
    Filed: February 4, 2009
    Date of Patent: July 14, 2015
    Assignee: EMMETROPE, INC.
    Inventors: Jeffrey L. Goldberg, Alan Halpern
  • Publication number: 20110003003
    Abstract: Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for treatment of disease and or injury.
    Type: Application
    Filed: February 4, 2009
    Publication date: January 6, 2011
    Inventors: Jeffrey L. Goldberg, Alan Halpern